recombinant live attenuated prophylactic vaccine (Top Institute/Erasmus/Merck/Wageningen University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant live attenuated prophylactic vaccine (Top Institute/Erasmus/Merck/Wageningen University)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsChikungunya Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTi Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWageningen University And ResearchErasmus University Medical CenterMerck & Co Inc +[4] 
Active IndicationsN/A
Inactive IndicationsChikungunya Fever

Other Information

ATC CodeN/A
Related LinksN/A